Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases. The Company is focused on developing therapies for patients with severe and life-threatening diseases. Atara operates through the business of developing and commercializing therapeutics segment.
Type | Public | |
Founded | 2012 | |
HQ | South San Francisco, CA, US | Map |
Website | atarabio.com | |
Employee Ratings | More | |
Overall Culture | F | More |
USD | |
---|---|
Net income (Q2, 2020) | (77.5m) |
EBIT (Q2, 2020) | (78.0m) |
Market capitalization (23-Feb-2021) | 1.4b |
Closing stock price (23-Feb-2021) | 16.8 |
Cash (30-Jun-2020) | 74.5m |
EV | 1.3b |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General and administrative expense | 1.7m | 3.5m | 3.6m | 4.1m | 5.8m | 6.5m | 7.1m | 8.6m | 9.6m | 11.1m | 14.0m | 19.2m | 16.9m | 19.2m | 23.3m | 19.0m | 17.0m | 16.4m |
R&D expense | 4.2m | 5.8m | 7.0m | 8.1m | 11.2m | 13.0m | 18.8m | 17.5m | 18.3m | 20.6m | 28.5m | 33.4m | 43.4m | 48.7m | 52.3m | 53.5m | 57.7m | 61.6m |
Operating expense total | 5.9m | 9.3m | 10.6m | 12.3m | 17.1m | 19.5m | 25.9m | 26.2m | 27.9m | 31.7m | 42.5m | 52.6m | 60.2m | 67.9m | 75.5m | 72.6m | 74.7m | 78.0m |
EBIT | (5.9m) | (9.3m) | (15.1m) | (12.3m) | (17.1m) | (19.5m) | (25.9m) | (26.2m) | (27.9m) | (31.7m) | (42.5m) | (52.6m) | (60.2m) | (67.9m) | (75.5m) | (72.6m) | (74.7m) | (78.0m) |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 25.7m | 71.3m | 26.2m | 54.5m | 22.1m | 26.4m | 46.0m | 62.4m | 64.2m | 60.5m | 90.5m | 103.2m | 66.0m | 56.2m | 59.2m | 94.4m | 70.2m | 74.5m |
Prepaid Expenses | 323.0k | 3.0m | 5.6m | 6.0m | 5.1m | 4.1m | 3.9m | 4.5m | 5.4m | 5.8m | 6.1m | 7.9m | 8.2m | 13.1m | 10.8m | 10.3m | 14.4m | 11.1m |
Current Assets | 52.0m | 169.7m | 160.6m | 340.2m | 311.7m | 298.9m | 282.2m | 235.3m | 222.5m | 206.2m | 413.6m | 425.1m | 373.0m | 250.8m | 201.1m | 293.4m | 229.2m | 359.0m |
PP&E | 14.0k | 47.0k | 42.0k | 46.0k | 1.1m | 1.8m | 2.1m | 4.4m | 20.3m | 22.2m | 58.2m | 66.1m | 68.3m | 58.1m | 57.1m | 55.7m | 54.4m | 53.6m |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (17.5m) | (9.2m) | (24.1m) | (36.0m) | (16.6m) | (35.4m) | (60.8m) | (25.7m) | (53.1m) | (84.2m) | (41.4m) | (92.3m) | (150.7m) | (66.3m) | (140.6m) | (212.5m) | (73.5m) | (151.0m) |
Depreciation and Amortization | 4.0k | 6.0k | 11.0k | 21.0k | 15.0k | 79.0k | 210.0k | 206.0k | 428.0k | 678.0k | 333.0k | 1.1m | 2.3m | 1.6m | 1.9m | 4.0m | ||
Accounts Payable | (37.0k) | 354.0k | 1.2m | 1.4m | 451.0k | 1.8m | 3.0m | (466.0k) | 253.0k | (1.0k) | (2.1m) | (207.0k) | 116.0k | 2.7m | 2.6m | 1.5m | (590.0k) | (2.9m) |
Cash From Operating Activities | (11.7m) | (6.6m) | (12.9m) | (25.8m) | (12.5m) | (23.3m) | (38.9m) | (22.0m) | (42.3m) | (62.6m) | (34.8m) | (74.3m) | (122.4m) | (70.2m) | (124.8m) | (176.9m) | (67.0m) | (123.7m) |
USD | Q3, 2014 |
---|---|
Financial Leverage | -2.4 x |
FY, 2016 | |
---|---|
Phase I Trials Products | 3 |
Phase II Trials Products | 3 |
Phase III Trials Products | 1 |
Atara Biotherapeutics has 1.3k Twitter Followers. The number of followers has increased 7.1% month over month and increased 15% quarter over quarter
312
Tweets
1.2k
Following
1.3k
Followers
14
Tweets last 30 days
11.4
Avg. likes per Tweet
100%
Tweets with engagement
F
43/100
A+
90/100
A+
100/100
When was Atara Biotherapeutics founded?
Atara Biotherapeutics was founded in 2012.
Who are Atara Biotherapeutics key executives?
Atara Biotherapeutics's key executives are Pascal Touchon, Eric Dobmeier and Roy D. Baynes.
How many employees does Atara Biotherapeutics have?
Atara Biotherapeutics has 393 employees.
Who are Atara Biotherapeutics competitors?
Competitors of Atara Biotherapeutics include Praxis Precision Medicines, Resolve Therapeutics and Felix Biotechnology.
Where is Atara Biotherapeutics headquarters?
Atara Biotherapeutics headquarters is located at Building 83, 611 Gateway Blvd #900, South San Francisco.
Where are Atara Biotherapeutics offices?
Atara Biotherapeutics has offices in South San Francisco, Aurora, New York, Thousand Oaks and in 1 other location.
How many offices does Atara Biotherapeutics have?
Atara Biotherapeutics has 5 offices.
Receive alerts for 300+ data fields across thousands of companies